Injective, a cryptocurrency that is gaining attention, has multiple price predictions making it seem like it is a worthwhile investment.
Pineapple Financial has started moving its $10B mortgage portfolio onto the blockchain by using Injective. With
Canary updating
staked Injective ETF with the SEC, INJ price is predicted to rebound. Furthermore, Injective has formed a partnership with Republic to champion investment in private firms such as SpaceX. With the discussions on how to buy Injective via various exchanges, it's speculated that Injective ETF could revolutionize institutional crypto adoption.
NYSE firm is said to have started buying INJ, further raising its price prediction. Pineapple Financial launches the first corporate Injective treasury with $100M investment while Injective launches
SBET, the first on-chain digital treasury. Various guides for beginners on Injective staking plus a price prediction suggesting that INJ could reach $40 after RWA booming up to $6B have been mentioned. Asset Manager,
Canary Capital, filed for the first staked Injective ETF adding to the list of products. Furthermore, the
smart money stacks Injective crypto with Token6900 raises $1.9M whereas Injective introduces a no-code platform for web3 builders. Canary has also filed for staked Injective ETF. Among the top cheap cryptocurrencies to buy are Injective, DeepSnitch AI, and Brett. Interest in altcoin funds has precipitated the filing for a new INJ ETF by
21Shares. The improvements in the crypto market encapsulates VeChain, The Graph, and Injective. With a native EVM being launched by Injective, promising faster and cheaper Defi, an upside price breakout is brewing for
INJ after bouncing off support.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Sat, 20 Dec 2025 01:29:33 GMT -
Rating 5
- Innovation 7
- Information 6
- Rumor 8
